<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>ECRI.org Emerging Technology Reports</title><link>https://members2.ecri.org/Components/target/</link><copyright>Copyright 2010 ECRI</copyright><description>New and Updated TARGET Reports</description><language>en-us</language><lastBuildDate>7/31/2010 4:25:32 PM</lastBuildDate><pubDate>7/31/2010 4:25:32 PM</pubDate><ttl>5</ttl><webMaster>htais@ecri.org</webMaster><item><title>Remote catheter navigation during radiofrequency ablation for cardiac arrhythmias</title><link>https://members2.ecri.org/Components/Target/Pages/10446.aspx</link><description> Radiofrequency ablation (RFA) is a catheter-based, minimally invasive treatment for cardiac arrhythmia (i.e., atrial fibrillation [AF], ventricular tachycardia, supraventricular tachycardia, atrioventricular reentrant tachycardia) that has not responded to optimal medical management. Optimal medical management includes lifestyle changes and antiarrhythmic drug therapy.</description><pubdate>7/19/2010</pubdate></item><item><title>Ventricular-assist devices (CentriMag) as temporary support for severe heart failure</title><link>https://members2.ecri.org/Components/Target/Pages/10160.aspx</link><description> A variety of mechanical circulatory support systems are designed to take a load off the heart and provide adequate perfusion of the organs in patients with heart failure. These systems include modifications of the original heart-lung machine circuits, such as extracorporeal membrane oxygenation and extracorporeal centrifugal pumps, which are generally intended for short-term use.</description><pubdate>6/29/2010</pubdate></item><item><title>Miniature intracardiac pump for acute heart failure</title><link>https://members2.ecri.org/Components/Target/Pages/10429.aspx</link><description> The Impella 2.5 Percutaneous Cardiac Support (PCS) System is a miniature intracardiac axial flow pump that can provide partial circulatory support for short periods of time (up to 6 hours in the United States and up to 5 days in Europe).</description><pubdate>6/18/2010</pubdate></item><item><title>Radiofrequency ablation for treatment of unresectable liver metastases</title><link>https://members2.ecri.org/Components/Target/Pages/10466.aspx</link><description> RFA is a procedure during which unresectable liver metasteses are heated to a temperature greater than 45°C with the intent of destroying the tumors while sparing surrounding normal tissue. If complete ablation of all liver tumors (which includes a 1 cm margin of tumor-free liver tissue) can be achieved, increased overall survival rates may be obtainable with RFA.</description><pubdate>5/20/2010</pubdate></item><item><title>Robotic-assisted laparoscopic radical prostatectomy for localized prostate cancer</title><link>https://members2.ecri.org/Components/Target/Pages/8766.aspx</link><description> Robot-assisted laparoscopic radical prostatectomy (RALRP), the focus of this report, is one of several surgical approaches to radical prostatectomy (RP)(surgical removal of the prostate, the seminal vesicles, and the vas deferens). RP is often recommended for patients with clinically localized prostate cancer.</description><pubdate>5/17/2010</pubdate></item></channel></rss>